for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Fosun Pharma says BioNTech to supply 100 mln doses of COVID-19 vaccine to China

Dec 16 (Reuters) - Shanghai Fosun Pharmaceutical Group said on Wednesday that BioNTech SE agreed to supply 100 million doses of its COVID-19 vaccine, if approved, to mainland China next year.

Pfizer and BioNTech’s COVID-19 vaccine has already received approval for emergency use in several countries, including the U.S., UK, and Singapore. (Reporting by Nikhil Kurian Nainan in Bengaluru Editing by Shri Navaratnam)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up